Treatment merits of Latanoprost / Thymoquinone – encapsulated liposome for glauc

Last updated 28th Jul 2017
Follow pinboard


A pinboard by Heba Fahmy

Lecturer, Biophysics Department, Faculty of Science, Cairo University


The aim of this study was to develop novel liposomal drug carriers for ocular delivery of Latanopros

Glaucoma is an optic neuropathy disease that is considered to be the second leading cause of blindness worldwide after cataract. Latanoprost (LAT) is a type of Prostaglandin derivative that has be...